Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | transient receptor potential cation channel, subfamily C, member 4 | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Human immunodeficiency virus 1 | Aberrant vpr protein | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Echinococcus multilocularis | short transient receptor potential channel 6 | transient receptor potential cation channel, subfamily C, member 4 | 890 aa | 799 aa | 31.2 % |
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | short transient receptor potential channel 6 | 0.0078 | 0.4782 | 0.462 |
Schistosoma mansoni | transient receptor potential channel 4 | 0.0117 | 1 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.4647 | 0.4647 |
Schistosoma mansoni | transient receptor potential channel | 0.0117 | 1 | 1 |
Echinococcus granulosus | transient receptor potential ion channel A | 0.0113 | 0.9486 | 0.947 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.0321 | 0.0321 |
Echinococcus multilocularis | transient receptor potential gamma protein | 0.0117 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.4647 | 0.4647 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0302 | 0.0649 |
Echinococcus granulosus | TRP transient receptor potential channel | 0.0044 | 0.0321 | 0.002 |
Echinococcus multilocularis | short transient receptor potential channel 6 | 0.0078 | 0.4782 | 0.462 |
Brugia malayi | RNA binding protein | 0.0076 | 0.4647 | 1 |
Echinococcus multilocularis | short transient receptor potential channel 6 | 0.0078 | 0.4782 | 0.462 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0302 | 0.0302 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0302 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.4647 | 0.4647 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.4647 | 1 |
Echinococcus granulosus | short transient receptor potential channel 6 | 0.0078 | 0.4782 | 0.462 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0302 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.2504 | 0.2504 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0302 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.4647 | 0.4647 |
Echinococcus multilocularis | transient receptor potential ion channel A | 0.0113 | 0.9486 | 0.947 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.4647 | 0.448 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.2504 | 0.2504 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.4647 | 0.4647 |
Brugia malayi | Transient-receptor-potential like protein | 0.0044 | 0.0321 | 0.069 |
Schistosoma mansoni | transient receptor potential channel | 0.0078 | 0.4782 | 0.4782 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.4647 | 0.4647 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.4647 | 0.4647 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0302 | 0.0302 |
Schistosoma mansoni | transient receptor potential channel | 0.0078 | 0.4782 | 0.4782 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0302 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.4647 | 0.448 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.2504 | 0.5389 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.2504 | 0.5389 |
Loa Loa (eye worm) | hypothetical protein | 0.0117 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.4269 | 0.4269 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.4647 | 0.4647 |
Echinococcus multilocularis | TRP (transient receptor potential) channel | 0.0044 | 0.0321 | 0.002 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.4647 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AbsAC1000_uM (functional) | = 1.7 uM | PUBCHEM_BIOASSAY: In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504552] | ChEMBL. | No reference |
AbsAC35 (functional) | = 14.91 uM | PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
AbsAC35 (functional) | = 22.25 uM | PubChem BioAssay. Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
EC50 (functional) | 7.4973 uM | PUBCHEM_BIOASSAY: Confirmation dose response assay for compounds that inhibit transient receptor potential cation channel C4 (TRPC4). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2247, AID2256] | ChEMBL. | No reference |
Potency (functional) | = 0.1585 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 1.7783 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 1.9953 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.5481 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.